Global Gamma Oryzanol Market Size, Trend & Opportunity Analysis Report, by Application (Sports Supplement, Cosmetic, Pharmaceutical, Animal Feed), and Forecast, 2024–2035

Market Definition and Introduction

The global gamma oryzanol market was valued at USD 2.23 billion in 2024 and is anticipated to reach USD 3.36 billion by 2035, expanding at a CAGR of 3.8% during the forecast period (2024–2035). Flowing uphill momentum on functional foods and nutraceuticals, gamma oryzanol, a hot commodity derived mainly from oil extracted from rice bran-has been in greater demand. From the reduction of cholesterol to the improvement of performance in athletes, gamma oryzanol fetches a high price as a nutraceutical ingredient owing to its proven health benefits and antioxidative effects. With increasing consumer awareness regarding lifestyle diseases such as obesity and cardiovascular diseases, gamma oryzanol makes its way into most supplement products and fortified foods. Their therapeutic marketed formulations are being made by pharmaceutical companies, mainly for stress reduction, hormone balance, and cardiovascular issues creating thus establishing gamma oryzanol as a functional compound for multiple applications.

The cosmetics industry has also made gamma oryzanol into its own, using it as a skin protection capacity for filtering UV rays and anti-ageing, thus providing a niche in the sun-care and dermatological segments. Wellness, personal care, and treatment benefit convergence promises rapid growth in commercial relevance. The animal feed industry is no exception; meanwhile, incorporation of gamma oryzanol optimises livestock growth performance and overall health performance, especially in poultry and equine nutrition. This diversification in end-use industries presents a steady growth loan, which will protect the market against growing dependence on one segment alone.

On the supply front, however, major participants are ramping up investments aimed at refining technologies that maximise the efficiency of extracting the active component while preserving the purity of the product. In addition, an increasing number of rice bran oil processing units is emerging in Asia, along with rising export opportunities. These developments have fortified supply chain resilience to gamma oryzanol. There are sustainability concerns that will shape the production ecosystem since manufacturing involves eco-friendly refining methods that reduce by-product wastage. Such evolution mirrors the overall market transformation, where science-driven innovation, health-conscious consumers, and regulatory support are together fuelling gamma oryzanol's journey from a niche extract to one of the essentials in global health and wellness.

Recent Developments in the Industry

TSUNO Group advances extraction technologies for higher purity levels.

January 2024 saw TSUNO Group launch a state-of-the-art oil refining process for rice bran for the enhanced purity yield of gamma oryzanol. This launch aligns with the strategic objective of the company to expand to the high-end nutraceuticals category with better bioavailability.

Fuji Oil Group expands nutraceutical product portfolio in Asia-Pacific.

In March 2024, the Fuji Oil Group announced that it would introduce gamma oryzanol supplements in Japan and China, considering the growing need for cholesterol-lowering functional food ingredients.

ADM invests in rice bran processing to secure the gamma oryzanol supply chain.

In July 2023, the Archer Daniels Midland Company (ADM) established new rice bran oil refining plants in Vietnam. This is a part of the company's strategy to see sustainable sourcing of gamma oryzanol for the global nutraceutical market at large.

Ricela Health Foods Launches Cosmetic-grade Gamma Oryzanol Solutions.

In September 2024, Ricela Health Foods unveiled a new cosmetic-grade gamma oryzanol intended for use in anti-ageing creams and sunscreens to capture the personal care market, which is booming in Europe.

Delekang Food collaborates with pharma companies for clinical studies.

In May 2025, Delekang Food Co., Ltd, collaborated with leading pharmaceutical companies in China regarding gamma oryzanol's efficacy in treating anxiety and stress, thus paving the way for new therapeutic avenues.

Market Dynamics

Functional foods and supplements create a strong market demand for gamma oryzanol across the globe.

Demand for gamma oryzanol has quadrupled and skyrocketed into mainstream health regimes due to consumers shifting towards the preference of natural ingredients in dietary supplements. The attributes of gamma oryzanol that fit with nutraceutical trends worldwide include the cholesterol-reducing and antioxidant properties, as well as enhancing performance in sports. Coupled with rising disposable incomes and awareness of preventive healthcare, the demand is set to witness stable upward momentum.

Cosmetic innovations boost gamma-oryzanol adoption in personal care markets.

Gamma oryzanol is becoming a common agent for UV protection or anti-ageing properties for skincare and sun-care products. Since such a trend is marked with a burgeoning shift toward naturally derived active ingredients for the global personal care industry, the uptake of oryzanol into premium creams, lotions, and, indeed, sunscreens is enhanced. This coherence will sustain growing markets in developed parts of the world vis-à-vis consumer anticipation of green beauty products.

Therapeutic formulations from various avenues widen the pharmaceutical scope.

Pharma houses are now exploring gamma oryzanol for its possible contribution to cardiovascular health and hormonal balance, as well as mental well-being. With increasing clinical studies, gamma oryzanol is being marketed as an adjunct therapy in stress, anxiety, and cholesterol management. Although early in development, this pharmaceutical application promises high-margin reward for market players undertaking evidence-backed product development.

Animal feed demands increase in equine and poultry nutrition.

Gamma oryzanol has established its niche in animal feed, especially for equine nutrition, where it promotes muscle growth, stamina, and performance. In poultry, its antioxidant properties have been utilised to enhance immunity and overall productivity. This diversification of applications protects the market from cyclical demand patterns in nutraceuticals and cosmetics.

Raw Material Dependency and Extraction Costs Present Industry Challenges

If anything, such potential markets are limited by high dependence on the availability of rice bran oil, which is largely contributed by the Asian region. Costly extraction and refining processes further create a feasible problem in scaling up. Rice production volatility and conflicts with edible competition for rice bran oil seemed to continue limiting the access and easy flow of raw materials from suppliers to gamma oryzanol manufacturers.

Attractive Opportunities in the Market

Nutraceutical Innovation Growth – Rising demand for preventive health supplements spurs innovation in gamma oryzanol formulations
Pharmaceutical R&D Momentum – Clinical studies drive therapeutic exploration for stress relief and cardiovascular health applications
Cosmetic Ingredient Expansion – Increasing adoption of oryzanol in anti-ageing and sun-care products enhances growth opportunities
Animal Feed Applications Rise – Equine and poultry nutrition demand supports diversification of gamma oryzanol end-use industries
Eco-Friendly Extraction Methods – Green refining techniques enhance sustainability while reducing wastage in rice bran oil processing
Asia-Pacific Manufacturing Base – Regional rice bran oil abundance fosters supply chain stability and production scalability
Premium Functional Food Growth – Fortified food and beverages open new consumer pathways for oryzanol integration
Strategic Collaborations Surge – Partnerships between pharma and food firms accelerate evidence-backed product development
Digital Health Marketing Boom – Online wellness platforms expand consumer reach for oryzanol-based supplements globally
Regulatory Support Momentum – Compliance with global nutraceutical safety standards boosts consumer trust and adoption rates

Report Segmentation

By Application: Sports Supplement, Cosmetic, Pharmaceutical, Animal Feed

By Region: North America (U.S., Canada, Mexico), Europe (UK, Germany, France, Spain, Italy, Spain, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South Korea, Rest of Asia-Pacific), LAMEA (Brazil, Argentina, UAE, Saudi Arabia (KSA), Africa Rest of Latin America)

Key Market Players

TSUNO Group, Oryza Oil & Fat Chemical Co., Henry Lamotte Oils GmbH, Okayasu Shorten Co. Ltd., Ricela Health Foods Ltd., Delekang Food Co. Ltd., Jining Ankang Pharmaceuticals, Fuji Oil Group, Archer Daniels Midland Company (ADM), and Henry Lamotte Oils Inc.

Report Aspects

Base Year: 2024
Historic Years: 2022, 2023, 2024
Forecast Period: 2024-2035
Report Pages: 293

Dominating Segments

Sports Supplement Segment Dominated by Increasing Demand for Performance-Enhancing Nutraceuticals

The category for sports supplements is the predominant segment of the gamma oryzanol market due to the increased use of this nutrient by athletes and fitness enthusiasts. Gamma oryzanol is known for its functions in supporting muscle growth and in boosting stamina while reducing recovery times from injury or exertion. This has made it a significant component of the sports nutrition niche. With a growing fitness culture, especially with the onslaught of premium supplement brands marketing natural products, sports supplements will have a lion's share. Nutraceutical approvals also provide regulatory backing and, therefore, legitimise this market dominance.

Evidence-based clinical adoption to capture pharmaceutical applications

The progressive acceptance of gamma oryzanol by the pharmaceutical industry is bolstered by clinical research endorsing its therapeutic value. The cholesterol-lowering properties, possible modulation of hormone levels, and reduction of stress and anxiety would render it good fodder for incorporation in formulations for pharmaceuticals. With personalised medicines and preventive healthcare garnering momentum, pharma-grade oryzanol is also expected to grow in leaps and bounds. Manufacturers have significantly invested in high-purity and good manufacturing practice-certified formulations in compliance with stringent regulatory requirements, marking a signal of huge potential in the future.

The cosmetics segment is witnessing a rise because of natural skincare and anti-ageing trends.

Currently, gamma oryzanol is considered a premium active ingredient in cosmetics and is becoming increasingly acknowledged for its natural antioxidative and UV-blocking properties. Moreover, it is being increasingly included in sun-care lotions and anti-ageing serums, and in high-end dermatological products. The adoption curve in this particular case is steep, with the consumer shift towards clean beauty and eco-friendly cosmetic formulations. Indeed, consumers in Europe and North America have a higher demand for naturally derived cosmetic actives, keeping the cosmetics segment on the growth track.

Stable share of animal feeds from horse and poultry nutrition.

Gamma oryzanol has had a solid market share in animal feeds and mostly in equine nutrition for developing muscles, stamina, and overall vitality. The application of gamma oryzanol in poultry use, however, has broadened since antioxidative properties were also utilised to enhance immunity and productivity. Smaller but consistent growth ensures that the market diversifies demand and provides sustainability in the long run. Combining that aspect with its utility in enhancing livestock performance puts it in contention for being a potential growth segment in the agricultural and feed industries.

Key Takeaways

Sports Nutrition Leadership – Gamma oryzanol leads in sports supplements, driven by rising fitness and wellness trends
Pharma Potential Rising – Clinical validation accelerates adoption in therapeutic formulations for cardiovascular and mental health
Cosmetics Market Growth – Natural skin-protective properties expand use in anti-ageing and sun-care cosmetics
Animal Feed Stability – Equine and poultry nutrition creates a consistent secondary demand base for gamma oryzanol
Asia-Pacific Dominance – Regional rice bran oil resources make Asia-Pacific the production hub of gamma oryzanol
Regulatory Backing Expands – Safety approvals and nutraceutical standards support global adoption across industries
Supply Chain Dependency – Reliance on rice bran oil availability continues to challenge cost structures and scalability
Eco-Friendly Extraction Push – Sustainable refining methods open opportunities for environmentally responsible manufacturing
Digital Health Channels – Online supplement distribution strengthens consumer reach and global market penetration
Collaborative R&D Efforts – Pharma, food, and cosmetic partnerships accelerate innovation in new formulations

Regional Insights

Nutraceutical innovations in North America receive the highest impetus through high consumer awareness and supportive regulations.

The North American gamma oryzanol market flourishes on increased consumer awareness about functional food and strong sports nutrition adoption. Thus, U.S. being the most complete nutraceutical ecosystem and the highest quality assurance standards, supplements research is spearheaded by America. Pharmaceutical companies now scout for oryzanol-based products to be used in cardiovascular- and stress-related ailments, while beauty gains ground in the region with natural actives increasingly being used in premium skincare products. Regulatory bodies like the FDA continue to endorse safe nutraceutical formulations; hence, a steady momentum in growth.

Europe has emerged as the foremost continent with grounds for adopting gamma oryzanol for cosmetics because of green beauty trends.

Europe has emerged as a cradle for cosmetic-grade gamma oryzanol backed by the booming skin and sun care industries of the continent. The demands for greener products drew up countries like Germany, France, and Italy, with consumption reaching considerable heights in the uptake of anti-ageing and UV-protection formulations. Furthermore, the stringent nutraceutical and pharmaceutical regulations in Europe push companies toward compliance, limiting their radical innovations to approved frameworks. This has transformed further production for the region based on sustainability and ethical sourcing.

Asia-Pacific will lead in terms of supplying and consuming these products, having a continuously strong base in industry and agriculture.

Asia-Pacific still holds the title of the largest and fastest-growing gamma oryzanol market. Countries like China, Japan, and India command rice bran oil production as well as nutraceutical consumption. Japan's prolonged history of adopting gamma oryzanol in supplements and pharmaceuticals denotes its maturity in the market; however, China and India are experiencing a surging demand for fortified foods, animal feed, and cosmetics. Expanding manufacturing capacity, along with favourable government perks, sees the Asia-Pacific continue to underpin global supply and push consumption growth.

Diversification approaches are undergoing across LAMEA with nutraceutical applications in animal feed.

The LAMEA region is small compared to other nations, but it is gradually harnessing in future benefits of gamma oryzanol. Brazil and Argentina are experimenting with fortified foods along with the nutraceutical sectors, while the Middle East and Africa are witnessing increasing integration of oryzanol in animal feeds along with some niche dietary posts. The growing investments in health and wellness infrastructure, with rising consumer interest in natural products, pave the way for the future of this still untapped region. Import arrangements with Asia-Pacific suppliers open doors for gradual expansion with availability.

Core Strategic Questions Answered in This Report

Q. What is the expected growth trajectory of the gamma oryzanol market from 2024 to 2035?

The global gamma oryzanol market is projected to grow from USD 2.23 billion in 2024 to USD 3.36 billion by 2035, registering a CAGR of 3.8%. This growth is underpinned by rising adoption across sports supplements, pharmaceuticals, cosmetics, and animal feed, with Asia-Pacific leading both production and consumption.

Q. Which key factors are fuelling the growth of the gamma oryzanol market?

Several key factors are propelling market growth:

Rising demand for nutraceuticals and functional foods across developed and emerging markets
Expanding applications in pharmaceuticals, cosmetics, and animal feed industries
Growing consumer preference for naturally derived health and beauty solutions
Technological advancements in eco-friendly extraction and refining techniques
Regulatory support for nutraceutical safety and therapeutic innovation

Q. What are the primary challenges hindering the growth of the gamma oryzanol market?

Major challenges include:

Heavy dependency on rice bran oil supply for raw material sourcing
High costs and complexities of extraction and refining processes
Competitive uses of rice bran oil for edible and industrial purposes
Stringent regulations are slowing product approvals in pharmaceuticals and cosmetics
Price volatility in the rice supply chain is impacting scalability and margins

Q. Which regions currently lead the gamma oryzanol market in terms of market share?

Asia-Pacific currently leads the gamma oryzanol market due to its abundant rice bran oil supply and strong nutraceutical adoption. North America follows closely with high consumer awareness in sports nutrition, while Europe drives cosmetic-grade applications through green beauty trends.

Q. What emerging opportunities are anticipated in the gamma oryzanol market?

The market is ripe with new opportunities, including:

Expansion of fortified foods and premium dietary supplements
Pharmaceutical exploration for cholesterol, stress, and hormone management therapies
Growth in cosmetic formulations for sun-care and anti-ageing segments
Development of sustainable extraction and refining methods
Strategic collaborations across pharma, cosmetics, and nutraceutical players

Key Benefits for Stakeholders

The report offers a quantitative assessment of market segments, emerging trends, projections, and market dynamics for the period 2024 to 2035.
The report presents comprehensive market research, including insights into key growth drivers, challenges, and potential opportunities.
Porter's Five Forces analysis evaluates the influence of buyers and suppliers, helping stakeholders make strategic, profit-driven decisions and strengthen their supplier-buyer relationships.
A detailed examination of market segmentation helps identify existing and emerging opportunities.
Key countries within each region are analysed based on their revenue contributions to the overall market.
The positioning of market players enables effective benchmarking and provides clarity on their current standing within the industry.
The report covers regional and global market trends, major players, key segments, application areas, and strategies for market expansion. Show more